Navigation Links
Irvine Pharmaceutical Services Introduces New Fill-and-Finish Subsidiary
Date:11/11/2008

IRVINE, Calif., Nov. 11 /PRNewswire/ -- Irvine Pharmaceutical Services, Inc., today announced the forthcoming January 2009 launch of Avrio Biopharmaceuticals. This venture is part of Irvine's overall growth strategy focused on improving its services and product offerings to current and potential clients.

Outfitted with an experienced team and state of the art equipment, Avrio Biopharma will provide a full range of formulation development and aseptic fill-and-finish services. It will be focused on developing optimized production processes and providing dependable filling, lyophilization and packaging capabilities for early phase clinical trial materials.

"We are very excited about this extension of our company," said Assad J. Kazeminy, CEO and Founder of Irvine Pharmaceutical Services. "Avrio will help round out our existing capabilities and its connection to Irvine will also make it possible to provide our clients with broader services via seamless partnership."

Since early 2007, Irvine Pharmaceutical Services, Inc., has experienced extensive growth and has made significant upgrades in its lab equipment and infrastructure. The opening of Avrio Biopharma is yet another step along the same growth lines, striving to better serve the needs of the company's clients and the pharmaceutical industry.

You can meet the team and learn more about Irvine and its new company, Avrio, at the AAPS Annual Meeting, booth 1707.

About Irvine

Irvine Pharmaceutical Services, Inc. is a fully integrated services provider that works with pharmaceutical, biotechnology and medical device companies through all phases of research and development. Founded in 1988 and committed to expansion and services that benefit its clients' priorities directly, Irvine is a fully cGMP compliant contract testing laboratory located in Irvine, CA. Visit http://www.irvinepharma.com or call (877) 445-6554.


'/>"/>
SOURCE Irvine Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion
2. Hoag Hospital Announces Agreement to Open Irvine Campus
3. Lucas Group to Host Military Hiring Conferences in Washington, DC; Irvine, CA and Dallas, TX
4. UC Irvine to lead statewide program on green materials research
5. UC Irvine researchers present latest findings at emergency medicine forum
6. UC-Irvine scientists present groundbreaking research at Society for Neuroscience conference
7. KV Pharmaceutical to File Form 12b-25 on November 12, 2008
8. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
10. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
11. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... PORT RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... use disorder, but concern for women who become dependent on opioid painkillers has fallen ... among female patients, compared to a 237% increase in fatal overdoses in male populations.(1) ...
(Date:2/27/2017)... ... ... Orange County dentist, Dr. A. Rassouli, comments on the new ... bacteria in plaque infect the gums and other tissues supporting the teeth. Treatment typically ... SRP, and can include surgical therapies if the condition has led to significant damage. ...
(Date:2/27/2017)... ... ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme and Associated ... Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) dismiss any ... into a single volume a compelling argument that the disease does exist in his ...
(Date:2/27/2017)... Francisco, CA (PRWEB) , ... February 27, 2017 ... ... center for hair transplantation therapy, is proud to announce a new informational post ... hair therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of ... concern over nerve agents and the deadly use of chemical weapons. Many questions exist ... how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017   Royal Philips (NYSE: ... in health technology, today announced 510(k) clearance from ... market its ElastQ Imaging capability, further expanding the ... ElastQ Imaging enables simultaneous imaging of tissue and ... the diagnosis of various liver conditions. With ElastQ ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
(Date:2/27/2017)... , Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) ... Adam Craig , M.D., Ph.D., as President and Chief Executive ... March 20, 2017. Dr. Craig succeeds Richard Love , ... the company,s Board of Directors.  Dr. Craig has over 20 ... both the US and Europe . ...
Breaking Medicine Technology: